By employing peptide-centered techniques to inhibit anti-apoptotic proteins like BCL-two, programmed cell Loss of life can be induced in cancer cells, in the long run leading to their demise. These targeted methodologies show encouraging results in augmenting the effectiveness of cancer therapy and enhancing patient outcomes. By means of these c